India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
Abhishek Sharma broke his own national record for the most centuries in the T20 cricket…
India delivered a spectacular batting performance against New Zealand in the third T20 International match…
The Ellora Caves are one of the greatest examples of rock-cut architecture found in India.…
According to the International Union for Conservation of Nature (IUCN), almost all assessed shallow-water coral…
The National Capital Region Transport Corporation (NCRTC) has been conferred with the award for Metro…
The Council of Ministers of Jammu & Kashmir was recently enlarged with four legislators taking…